Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Sitemap: |
Title | BYDUREON BCise® (exenatide extended-release) injectable suspension 2 mg | Home | For |
Description | IMPORTANT SAFETY Learn about dosing, safety, side effects, savings program and patient resources for BYDUREON BCise® (exenatide extended-release) from the official HCP |
Keywords | N/A |
WebSite | bydureonhcp.com |
Host IP | 54.192.58.43 |
Location | United States |
Site | Rank |
US$5,805,268
Last updated: 2023-05-10 03:34:59
bydureonhcp.com has Semrush global rank of 1,823,224. bydureonhcp.com has an estimated worth of US$ 5,805,268, based on its estimated Ads revenue. bydureonhcp.com receives approximately 669,839 unique visitors each day. Its web server is located in United States, with IP address 54.192.58.43. According to SiteAdvisor, bydureonhcp.com is safe to visit. |
Purchase/Sale Value | US$5,805,268 |
Daily Ads Revenue | US$5,359 |
Monthly Ads Revenue | US$160,762 |
Yearly Ads Revenue | US$1,929,136 |
Daily Unique Visitors | 44,656 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
bydureonhcp.com. | A | 299 | IP: 54.192.58.43 |
bydureonhcp.com. | A | 299 | IP: 54.192.58.14 |
bydureonhcp.com. | A | 299 | IP: 54.192.58.102 |
bydureonhcp.com. | A | 299 | IP: 54.192.58.62 |
bydureonhcp.com. | NS | 300 | NS Record: ns-492.awsdns-61.com. |
bydureonhcp.com. | NS | 300 | NS Record: ns-531.awsdns-02.net. |
bydureonhcp.com. | NS | 300 | NS Record: ns-1309.awsdns-35.org. |
bydureonhcp.com. | NS | 300 | NS Record: ns-1745.awsdns-26.co.uk. |
bydureonhcp.com. | TXT | 300 | TXT Record: facebook-domain-verification=4tpvr80qvndrqkp9hrs75n4py1dccm |
For US Healthcare Professionals For Patients En Español Instructions for Use, Approved Uses, Prescribing Information, including Boxed WARNING ... + Instructions for Use, Approved Uses, Prescribing Information, including Boxed WARNING ... + Indication and Limitations of Use Important Safety Information Prescribing Information, including Boxed WARNING Medication Guide Instructions for Use X INDICATION AND LIMITATIONS OF USE BYDUREON and BYDUREON BCise are both indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus Not recommended as first-line therapy for patients inadequately controlled on diet and exercise Not a substitute for insulin. Should not be used to treat type 1 diabetes or diabetic ketoacidosis Not recommended for use with insulin Do not coadminister with other exenatide-containing products Not studied in patients with a history of pancreatitis. Consider other antidiabetic therapies in patients with a history of |
HTTP/1.1 403 Forbidden Server: CloudFront Date: Tue, 02 Nov 2021 01:59:16 GMT Content-Type: text/html Content-Length: 919 Connection: keep-alive X-Cache: Error from cloudfront Via: 1.1 77dc26119e8c7a5f9e0061e54df1d307.cloudfront.net (CloudFront) X-Amz-Cf-Pop: MSP50-C2 X-Amz-Cf-Id: _9alE0fThGN5bit9elO6iO1hlyN12sYs4basc18R4cP7ZQDAR-cxkQ== |
Domain Name: BYDUREONHCP.COM Registry Domain ID: 1586004382_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2016-01-29T09:09:48Z Creation Date: 2010-02-19T20:18:23Z Registry Expiry Date: 2022-02-19T20:18:23Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-1309.AWSDNS-35.ORG Name Server: NS-1745.AWSDNS-26.CO.UK Name Server: NS-492.AWSDNS-61.COM Name Server: NS-531.AWSDNS-02.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-20T10:43:44Z <<< |